Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
1
20%
Ph phase_3
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (66.7%)
Phase 41 (33.3%)

Trials by Status

completed360%
recruiting120%
active_not_recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_4

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

NCT07354269
active_not_recruitingphase_3

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

NCT05951725
completed

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

NCT00855855
completed

Database Surveillance Safety Study of PENTACEL® Vaccine

NCT00804284
completedphase_3

A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months

NCT01000311

Clinical Trials (5)

Showing 5 of 5 trials
NCT07354269Phase 4

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

Recruiting
NCT05951725Phase 3

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

Active Not Recruiting
NCT00855855

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

Completed
NCT00804284

Database Surveillance Safety Study of PENTACEL® Vaccine

Completed
NCT01000311Phase 3

A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months

Completed

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5